Impact of moderate alcohol consumption on hepatic fibrosis progression in HCV-infected patients

被引：0
|
作者：
Barjoan, E. Marine
Gelsi, E.
Delasalle, P.
Ibragimova, N.
Sattonnet, C.
Saint-Paul, M. C.
Gueyffier, C.
Diebolt, E.
Hayek, R.
Fuzibet, J. G.
Ouzan, D.
Tran, A.
机构：
[1] Univ Hosp, Liver Unit, Nice, France
[2] Univ Hosp, HCV Cote Azur Network, Nice, France
[3] Univ Hosp, Dept Pathol, Nice, France
[4] Gen Hosp, Dept Gastroenterol, Cannes, France
[5] Gen Hosp, Dept Gastroenterol, Menton, France
[6] Univ Hosp, Dept Internal Med, Nice, France
[7] A Tzank Inst, St Laurent Du Var, France
来源：
JOURNAL OF HEPATOLOGY | 2007年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
731
引用
收藏
页码：S275 / S276
页数：2
相关论文
共 50 条
  • [31] Ability of EMR-based fibrosis scores to identify HCV-infected patients with cirrhosis
    Khan, Mohammad Qasim
    Anand, Vijay
    Hassan, Ammar
    Assan, Alya
    Sonnenberg, Amnon
    Fimmel, Claus J.
    HEPATOLOGY, 2015, 62 : 1081A - 1081A
  • [32] Underestimated impact of alcohol consumption on the progression of fibrosis in patients transplanted for HCV-related cirrhosis: A comparative study with transplanted for alcohol-related cirrhosis
    Sobesky, R
    Francoz, C
    Paradis, V
    Belghiti, J
    Valla, D
    Marcellin, P
    Durand, F
    LIVER TRANSPLANTATION, 2006, 12 (05) : C113 - C113
  • [33] The impact of coffee consumption on fibrosis and steatosis in HIV-HCV co-infected patients
    Carrieri, Maria Patrizia
    Protopopescu, Camelia
    Marcellin, Fabienne
    Wittkop, Linda
    Lacombe, Karine
    Esterle, Laure
    Sogni, Philippe
    Salmon-Ceron, Dominique
    JOURNAL OF HEPATOLOGY, 2018, 68 (04) : 845 - 847
  • [34] HCV-infected dialysis patients: History is changing
    Parlati, Lucia
    Pol, Stanislas
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2019, 43 (03) : 225 - 227
  • [35] From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression
    Wang, Y.
    Li, J.
    Chen, J.
    Liu, L.
    Peng, Z.
    Ding, J.
    Ding, K.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2012, 16 (08) : 995 - 1000
  • [36] Adherence to therapy: Challenges in HCV-infected patients
    Pozza R.
    Barakat F.
    Current Hepatitis Reports, 2007, 6 (4) : 160 - 168
  • [37] Hepatic expression of interleukin-12 alters outcome in HCV-infected patients.
    Rai, R
    Anania, F
    Boitnott, J
    Diehl, AM
    Spoler, C
    Thomas, D
    GASTROENTEROLOGY, 1998, 114 (04) : A1325 - A1325
  • [38] SUSTAINED VIROLOGIC RESPONSE PREDICTS FIBROSIS REGRESSION MEASURED BY FIBROTEST IN HCV-INFECTED PATIENTS
    Forns, X.
    Welzel, T. M.
    Cohen, E.
    Jacobson, I. M.
    Davis, M.
    Reindollar, R.
    Hu, Y. B.
    Dylla, D. E.
    Enejosa, J. V.
    Trinh, R.
    Sulkowski, M. S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S829 - S830
  • [39] Current and Future Disease Progression of HCV-Infected Patients Among Different Age Cohorts
    Zalesak, Martin
    Francis, Kevin
    Kwong, Ann
    Li, Hong
    Martyn, Derek
    Orne, Leslie S.
    Smith, Amanda
    Hvidsten, Kyle
    GASTROENTEROLOGY, 2012, 142 (05) : S965 - S965
  • [40] Value of reelin as parameter for monitoring hepatic fibrogenesis in a group of Egyptian HCV-infected patients
    Mansy, S.
    Nosseir, M.
    Zoheiry, M.
    Othman, M.
    Hassanein, M.
    Guda, M.
    Yehia, H.
    Abotaleb, H.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 : 15 - 15
12345